MALDI Biotyper Sirius and Sirius One Systems Receive Environmental Sustainability Designation
Bruker's MALDI Biotyper sirius and sirius one systems have received the ACT Label from My Green Lab, recognizing responsible design.
Bruker's MALDI Biotyper sirius and sirius one systems have received the ACT Label from My Green Lab, recognizing responsible design.
Hepatitis B and C remain major global health threats due to persistent gaps in diagnosis, treatment access, and implementation of care.
Most Medicaid-enrolled children with autism or intellectual disability are not receiving recommended genetic testing.
A new survey finds that data overload remains a top challenge for labs, but is also an opportunity for AI-driven transformation.
Researchers have developed genomic biomarkers to predict cancer patients’ resistance to chemotherapy, enabling more personalized treatment.